Pharmaceutical Product Development, LLC (PPD) announced that its clinical research expertise was recognized for excellence at the PharmaTimes International Clinical Researcher of the Year competition.
At the London finale, a PPD clinical research associate (CRA) earned gold in the “Aspiring Clinical Research Associate” category. That award was in addition to last month’s Americas-based competition, in which two PPD CRAs won gold in the “Experienced Clinical Research Associate” and “New Clinical Research Associate” categories. PPD’s Lauren Cassidy earned gold at the London event on 17 May.
Both competitions featured a demanding, yearlong, three-part series of tests, including real-life challenges judged by industry leaders.
“PPD’s clinical researchers exemplify the highest levels of professionalism and competence, which have led to these notable industry recognitions,” said Roger Newbery, senior vice president of investigator services for PPD. “We congratulate them on their achievements and recognize the talent, success and dedication they bring to all of our clients in their efforts to develop life-changing medicines.”
The PharmaTimes competition provides a unique opportunity for clinical research professionals to compare their skills with those of their peers in a learning environment, and have their work judged by an independent panel of high-level industry leaders. The only competition of its kind for clinical researchers, it has offered the opportunity to recognize clinical excellence since 1999.
About PPD
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 47 countries and approximately 20,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health. For more information, visit www.ppdi.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180530005840/en/
Contacts
PPD
Media:
Randy Buckwalter, +1 919-456-4425
randy.buckwalter@ppdi.com
or
Investors:
Nate Speicher, +1 910-558-6783
nate.speicher@ppdi.com
Source: Pharmaceutical Product Development, LLC
